Sciatic nerve lipoprotein lipase is reduced in streptozotocin-induced diabetes and corrected by insulin

Endocrinology

Volumn 143, Issue 4, 2002, Pages 1213-1217

  Ferreira, L D M C B ^a   Huey, P U ^a   Pulford, B E ^b   Ishii, D N ^b   Eckel, R H ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPOPROTEIN LIPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEMYELINATION; DRUG EFFECT; ENZYME ACTIVITY; HYDROLYSIS; INSULIN TREATMENT; MOTOR NERVE CONDUCTION; NERVE FIBER DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SCHWANN CELL; SCIATIC NERVE; STREPTOZOCIN DIABETES;

EID: 0036206582     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.4.8723     Document Type: Article

References (47)

1. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases
2. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein
3. Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: Direct evidence that lipoprotein lipase bridging occurs in vivo
4. Lipoprotein lipase and acid lipase activity in rabbit brain microvessels
5. Lipoprotein lipase is produced, regulated, and functional in rat brain
6. Localization of lipoprotein lipase to discrete areas of the guinea pig brain
7. Spinal cord of the rat contains more lipoprotein lipase than other brain regions
8. Lipoprotein lipase is expressed in cultured Schwann cells and functions in lipid synthesis and utilization
9. Glycohemoglobin levels relate to the response of adipose tissue lipoprotein lipase to insulin/glucose in obese noninsulin-dependent diabetes mellitus
10. Lipoprotein lipases and diabetes mellitus
11. Lipoprotein lipase in diabetes
12. Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus
13. Brain lipoprotein lipase is responsive to nutritional and hormonal modulation
14. Central and peripheral nervous system complications
15. The impact of diabetes on the CNS
16. Metabolic alterations of peripheral nerve in diabetes
17. Prevention and treatment of the complications of diabetes mellitus
18. Impairment of spinal cord conduction velocity in diabetic rats
19. Methods for studying lipoprotein lipase in human adipose tissue
20. Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides
21. Plasma triglyceride reduction in mice after direct injections of muscle-specific lipoprotein lipase DNA
22. Diabetic neuropathies: Features and mechanisms
23. The effect of hyperglycemia on nerve conduction and structure is age dependent
24. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus
25. The effect of intensive treatment of diabetes therapy on the development and progression of neuropathy
26. Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels
27. Effect of improved diabetes control on the expression of lipoprotein lipase in human adipose tissue
28. Lipoprotein lipase gene expression in rat adipocytes is regulated by isoproterenol and insulin through different mechanisms
29. Synthesis and regulation of lipoprotein lipase in the hippocampus
30. Myelin synthesis in the peripheral nervous system
31. The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities
32. Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation
33. Correlation between the morphology and the lipid and protein compositions in the peripheral nervous system of individual 8-d-old normal and trembler mice
34. Peripheral neuropathy in cats with inherited primary hyperchylomicronaemia
35. Lipolytic activity of post-heparin plasma in hyperlipemia and hypolipemia
36. Neutral lipids of plasma and adipose tissue in abetalipoproteinemia
37. Peripheral neuropathy in abetalipoproteinemia
38. Vitamin E and neurological function: Abetalipoproteinaemia and other disorders of fat absorption
39. Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy
40. Vitamin E as a universal antioxidant and stabilizer of biological membranes
41. High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats
42. Functional recovery and vitamin E level following sciatic nerve crush injury in normal and diabetic rats
43. The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers
44. Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro
45. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus
46. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats
47. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy